MIAX's lower contract fees hurt earnings despite solid volume. Q3 revenue per contract is estimated at 9.8 cents, below 10.3-11 cents guidance; 2026 EBITDA falls to a modeled $270M from $285M. The short-term thesis is broken, but the long-term one holds. MEMX's higher rebates may signal a price war, though management has not confirmed this. MIAX is definitely cheap at about 10x 2026 EBITDA, but fair value has fallen. One bad quarter is no reason to sell unless the fee pressure proves lasting. x.comÂ